RGC logo

RGC Stock Overview

Profile

Full Name:

Regencell Bioscience Holdings Limited

Sector:

Healthcare

Industry:

Drug Manufacturers - Specialty & Generic

Country:

Hong Kong

IPO:

July 16, 2021

Indexes:

Not included

Website:

http://www.regencellbioscience.com

Description:

Regencell Bioscience Holdings Limited focuses on developing innovative treatments for neurological and psychiatric disorders. The company specializes in research and production of natural therapies, aiming to improve mental health and cognitive function through its unique formulations and advanced scientific methods.

Key Details

Price

$4.20

Market Cap

$54.65 M(Small cap)

Last Dividend

-

TTM Dividend Yield

-

Annual Revenue

-

Annual EPS

-$0.33(+26.67% YoY)

PE Ratio

-

Annual ROE

-52.34%

Annual Debt To Equity

0.01

Beta

0.01

Events Calendar

Earnings

Next earnings date:

Jun 20, 2025

Recent quarterly earnings:

Jun 20, 2024

Recent annual earnings:

Oct 29, 2021
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

N/A

Analyst ratings

Recent major analysts updates

No data about analysts updates

Screeners with RGC included

Hong Kong stocks
Stocks below SMA 200
Healthcare sector
All stocks
Small cap stocks
Stocks with low beta
Specialty & Generic Drug Manufacturers industry
NASDAQ earnings calendar

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Current Price

$4.20
RGC price is $4.20

Price All-time High

$46.33
RGC price is currently -90.93% below its historical high of $46.33

Price Analysts Target

-
RGC price consensus analysts' forecast is unknown

Price Most Recent Change

-2.33%
RGC price was down -2.33% on Feb 22, 2025

Price YTD Change

-18.6%
RGC price is down -18.6% since January 1st

Price 3-Year Change

-88.95%
RGC price is down -88.95% over the past 3 years

Market cap

Market Cap

$54.65 M
RGC market capitalization is $54.65 million

Market Cap 3-Year Change

-88.91%
RGC market capitalization is down -88.91% over the past 3 years

Market Cap All-time High

$595.80 M
RGC market capitalization is currently -90.83% below its historical high of $595.80 million

Market Cap Sector Rank

36.42%
RGC market capitalization is higher than 36.42% of companies in Healthcare sector

Technical

Beta

0.01
RGC beta is 0.01

200-day SMA

$5.71
RGC price is currently -26.43% below its 200-day simple moving average

14-day RSI

57.15
RGC 14-day relative strength index is 57.15

30-day Relative Volume

0.65
RGC 30-day relative volume is 0.65

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Annual Revenue

-
RGC annual revenue value is unknown

Annual Revenue Analysts Estimate

-
RGC annual revenue consensus analysts' forecast is unknown

Annual Revenue 1-Year Change

-
RGC annual revenue 1-year change is unknown

Annual Revenue Sector Rank

-
RGC annual revenue is unknown

Profit

Annual Gross Profit

-
RGC annual gross profit value is unknown

Annual Gross Margin

-
RGC annual gross profit margin value is unknown

Annual Operating Profit

-$4.74 M
RGC annual operating income is -$4.74 million

Annual Operating Margin

-
RGC annual operating profit margin value is unknown

Annual Net Income

-$4.30 M
RGC annual net profit is -$4.30 million

Annual Net Margin

-
RGC annual net profit margin value is unknown

EPS

Annual EPS

-$0.33
RGC annual earnings per share is -$0.33

Annual EPS Analysts Estimate

-
RGC annual earnings per share consensus analysts' forecast is unknown

Annual EPS 1-Year Change

+26.67%
RGC annual earnings per share is up +26.67% year-on-year

Annual EPS Sector Rank

75.85%
RGC annual earnings per share is higher than 75.85% of companies in Healthcare sector

ROA & ROE

Annual ROA

-50.98%
RGC annual return on assets is -50.98%

Annual ROE

-52.34%
RGC annual return on equity is -52.34%

EBIT & EBITDA

Annual EBIT

-$4.74 M
RGC annual earnings before interest & taxes is -$4.74 million

Annual EBITDA

-$3.99 M
RGC annual EBITDA is -$3.99 million

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE Ratio

-
RGC price to earnings ratio value is unknown

PE Ratio Sector Rank

-
RGC price to earnings ratio is unknown

PB Ratio

PB Ratio

6.65
RGC price to book ratio is 6.65

PB Ratio Sector Rank

87.14%
RGC price to book ratio is higher than 87.14% of companies in Healthcare sector

PS Ratio

PS Ratio

-
RGC price to sales ratio value is unknown

PS Ratio Sector Rank

-
RGC price to sales ratio is unknown

Enterprise value

Enterprise Value

$51.78 M
RGC enterprise value is $51.78 million

Enterprise Value Sector Rank

40.8%
RGC enterprise value is higher than 40.8% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-
RGC EV/EBITDA value is unknown

EV/EBITDA Sector Rank

-
RGC EV/EBITDA is unknown

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Annual Current Ratio

41.91
RGC annual current ratio is 41.91

Annual Quick Ratio

-
RGC annual quick ratio value is unknown

Leverage

Annual Debt To Equity

0.01
RGC annual debt to equity ratio is 0.01

Annual Interest Coverage Ratio

-
RGC annual interest coverage ratio value is unknown

Risk & Stability

Piotroski F-Score

-
RGC piotroski f-score value is unknown

Altman Z-Score

-
RGC altman z-score value is unknown

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Annual Total Assets

$8.44 M
RGC annual total assets is $8.44 million

Annual Non Current Assets

$324.20 K
RGC annual long term assets is $324.20 thousand

Annual Current Assets

$8.11 M
RGC annual total current assets is $8.11 million

Annual Cash & Cash Equivalents

$2.96 M
RGC annual cash & cash equivalents is $2.96 million

Equity

Annual Book Value

$8.22 M
RGC annual book value is $8.22 million

Annual Working Capital

$7.92 M
RGC annual working capital is $7.92 million

Liabilities

Annual Total Liabilities

$219.50 K
RGC annual total liabilities is $219.50 thousand

Annual Total Long Term Liabilities

$25.90 K
RGC annual total long term liabilities is $25.90 thousand

Annual Current Liabilities

$193.60 K
RGC annual total current liabilities is $193.60 thousand

Annual Accounts Payable

-
RGC annual accounts payable value is unknown

Debt

Annual Total Debt

$85.70 K
RGC annual total debt is $85.70 thousand

Annual Total Debt 1-Year Change

-81.52%
RGC annual total debt is down -81.52% year-on-year

Annual Long Term Debt

$25.90 K
RGC annual long term debt is $25.90 thousand

Annual Short Term Debt

$59.80 K
RGC annual short term debt is $59.80 thousand

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Annual Total Expenses

$4.74 M
RGC annual total expenses is $4.74 million

Annual Operating Expenses

$4.74 M
RGC annual total operating expenses is $4.74 million

Annual Cost Of Goods Sold

-
RGC annual cost of goods sold value is unknown

Annual SGA

$3.67 M
RGC annual SGA is $3.67 million

Annual D&A

$745.60 K
RGC annual depreciation & amortization is $745.60 thousand

Annual Interest Expense

-
RGC annual interest expense value is unknown

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Annual CFO

-$4.00 M
RGC annual cash flow from operations is -$4.00 million

Annual CFO 1-Year Change

+19.37%
RGC annual cash flow from operations is up +19.37% year-on-year

Annual CFI

$5.24 M
RGC annual cash flow from investing activities is $5.24 million

Annual CFI 1-Year Change

+8785.76%
RGC annual cash flow from investing activities is up +8785.76% year-on-year

Annual CFF

$102.30 K
RGC annual cash flow from financing activities is $102.30 thousand

Annual CFF 1-Year Change

-24.17%
RGC annual cash flow from financing activities is down -24.17% year-on-year

Free CashFlow

Annual FCF

-$4.01 M
RGC annual free cash flow is -$4.01 million

Annual FCF 1-Year Change

+19.7%
RGC annual free cash flow is up +19.7% year-on-year

CAPEX

Annual CAPEX

-
RGC annual capital expenditures value is unknown

Annual CAPEX 1-Year Change

-
RGC annual capital expenditures 1-year change is unknown

Institutional Ownership

Similar stocks

RPTX logo
Repare Therapeutics (RPTX)
APYX logo
Apyx Medical (APYX)
ONCY logo
Oncolytics Biotech (ONCY)
IMRX logo
Immuneering (IMRX)
ESLA logo
Estrella Immunopharma (ESLA)
RANI logo
Rani Therapeutics Holdings (RANI)
VNRX logo
VolitionRx Limited (VNRX)
VTVT logo
vTv Therapeutics (VTVT)
RMTI logo
Rockwell Medical (RMTI)

FAQ

  • What is the ticker symbol for Regencell Bioscience Holdings Limited?
  • Does Regencell Bioscience Holdings Limited pay dividends?
  • What sector is Regencell Bioscience Holdings Limited in?
  • What industry is Regencell Bioscience Holdings Limited in?
  • What country is Regencell Bioscience Holdings Limited based in?
  • When did Regencell Bioscience Holdings Limited go public?
  • Is Regencell Bioscience Holdings Limited in the S&P 500?
  • Is Regencell Bioscience Holdings Limited in the NASDAQ 100?
  • Is Regencell Bioscience Holdings Limited in the Dow Jones?
  • When was Regencell Bioscience Holdings Limited's last earnings report?
  • When does Regencell Bioscience Holdings Limited report earnings?

What is the ticker symbol for Regencell Bioscience Holdings Limited?

The ticker symbol for Regencell Bioscience Holdings Limited is NASDAQ:RGC

Does Regencell Bioscience Holdings Limited pay dividends?

No, Regencell Bioscience Holdings Limited does not pay dividends

What sector is Regencell Bioscience Holdings Limited in?

Regencell Bioscience Holdings Limited is in the Healthcare sector

What industry is Regencell Bioscience Holdings Limited in?

Regencell Bioscience Holdings Limited is in the Drug Manufacturers - Specialty & Generic industry

What country is Regencell Bioscience Holdings Limited based in?

Regencell Bioscience Holdings Limited is headquartered in Hong Kong

When did Regencell Bioscience Holdings Limited go public?

Regencell Bioscience Holdings Limited's initial public offering (IPO) was on July 16, 2021

Is Regencell Bioscience Holdings Limited in the S&P 500?

No, Regencell Bioscience Holdings Limited is not included in the S&P 500 index

Is Regencell Bioscience Holdings Limited in the NASDAQ 100?

No, Regencell Bioscience Holdings Limited is not included in the NASDAQ 100 index

Is Regencell Bioscience Holdings Limited in the Dow Jones?

No, Regencell Bioscience Holdings Limited is not included in the Dow Jones index

When was Regencell Bioscience Holdings Limited's last earnings report?

Regencell Bioscience Holdings Limited's most recent earnings report was on Jun 20, 2024

When does Regencell Bioscience Holdings Limited report earnings?

The next expected earnings date for Regencell Bioscience Holdings Limited is Jun 20, 2025